Cybin Announces Conditional Listing Approval from NYSE American Post published:July 22, 2021 Post category:Press Release
Red Light Holland Files New Patent: Technology and Devices for Monitoring Information and Influencing Behavior Involving Carbon Dioxide Emissions Post published:July 21, 2021 Post category:Press Release
Small Pharma Establishes Psychedelic-assisted Therapy Training Program Post published:July 21, 2021 Post category:Press Release
Tryp Therapeutics Announces Plans for Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan Post published:July 21, 2021 Post category:Press Release
PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation Post published:July 21, 2021 Post category:Press Release
Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds Post published:July 21, 2021 Post category:Press Release
Filament Health to Host Virtual Investor Event Post published:July 20, 2021 Post category:Press Release
Mindset Pharma Announces Appointment of Clinician Scientist, Dr. Ishrat Husain, to Scientific Advisory Board Post published:July 20, 2021 Post category:Press Release
Red Light Holland: Bruce Linton Confirms Intention to Chair The HighBrid Lab Board of Directors Post published:July 19, 2021 Post category:Press Release
Levitee Labs to Commence Trading on the Canadian Securities Exchange Under the Ticker Symbol āLVTā on Wednesday, July 21st 2021 Post published:July 19, 2021 Post category:Press Release